loadpatents
name:-0.01301121711731
name:-0.011491060256958
name:-0.00052189826965332
Hardern; David Patent Filings

Hardern; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hardern; David.The latest application filed is for "trisubstituted triazolopyrimidines for use in platelet aggregation inhibition".

Company Profile
0.4.11
  • Hardern; David - Cheshire GB
  • Hardern; David - Sutton Bonington GB
  • Hardern; David - Leics GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20150152111 - Hardern; David ;   et al.
2015-06-04
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibiton
App 20140296258 - Hardern; David ;   et al.
2014-10-02
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20130109702 - Hardern; David ;   et al.
2013-05-02
Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition
App 20130072503 - Hardern; David ;   et al.
2013-03-21
Novel compounds
App 20120165348 - Hardern; David ;   et al.
2012-06-28
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
App 20100069408 - Hardern; David ;   et al.
2010-03-18
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
App 20080214812 - Hardern; David ;   et al.
2008-09-04
Novel compounds
App 20070265282 - Hardern; David ;   et al.
2007-11-15
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
Grant 7,250,419 - Hardern , et al. July 31, 2
2007-07-31
Novel compounds
App 20060025590 - Hardern; David ;   et al.
2006-02-02
Compounds
Grant 6,974,868 - Hardern , et al. December 13, 2
2005-12-13
Novel compounds
App 20030144305 - Hardern, David ;   et al.
2003-07-31
Triazolo(4,5-d)pyrimidine compounds
Grant 6,525,060 - Hardern , et al. February 25, 2
2003-02-25
Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation
Grant 6,156,756 - Hardern , et al. December 5, 2
2000-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed